Temple Terrace, FL, United States
BayCare Integrated Service Center, LLC /dba BayCare Central Pharmacy recalls
3 recalls recorded since 2018, most recently on 1 December 2022. None are listed as ongoing. Status and classification are as published by the FDA.
Recalls3
Ongoing (FDA)0
Terminated or completed3
Class I (FDA)1
Terminated Class I Drugs
- Recall started
- 1 December 2022
- Terminated
- 15 March 2024
- Reason
- Labeling: Label Error on Declared Strength: syringes mislabeled as 300 mg iodine/mL contained product 350 mg iodine/mL
- Distribution
- BayCare Health System hospitals in FL
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0086-2023
- Iohexol (300 mg Iodine/mL), 2.4 g Iodine/8 ml, Total Volume 8 ml in 10 ml syringe, 5-count syringes packaged in a bag labeled as Omnipaque (iohexol) 300 mg I/mL, 2.4g Iodine/8 mL in a 10 mL syringe, Compounded with GE He
Terminated Class III Drugs
- Recall started
- 14 February 2022
- Terminated
- 8 December 2022
- Reason
- Subpotent drug
- Distribution
- Florida
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0569-2022
- Norepinephrine bitartrate 16 mg in 250 mL NaCl 0.9%, packaged in IV bags, Rx only, BayCare Central Pharmacy 7802 E. Telecom Parkway Temple Terrace, FL 33637 (813) 901-6392
Terminated Class II Drugs
- Recall started
- 30 July 2021
- Terminated
- 22 October 2021
- Reason
- Lack of sterility assurance
- Distribution
- FL
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0702-2021
- Succinylcholine Chloride 100 mg/5 mL (20 mg/mL), 5 mL Syringes, Rx only, For IV Use only, BayCare Central Pharmacy, 7802 E. Telecom Parkway, Temple Terrace, FL 33837
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.